This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base

Pharma Stock Aurinia, With 1,854% Earnings Growth Potential, Forms Bullish Base | Investor's Business DailyBREAKING: [Dow Jones Tops 50,000, But Nasdaq Below Key Level]---Many of the stock market's big winners, such as the so-called Magnificent Seven, have been having challenging times of late. But pharma stock Aurinia Pharmaceuticals (AUPH) is currently forming a bullish chart pattern despite the carnage on the broader stock market. The Canadian company is known for its Lupkynis medicine, which dominates t ...